Your browser doesn't support javascript.
loading
Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies.
Olsson, R F; Logan, B R; Chaudhury, S; Zhu, X; Akpek, G; Bolwell, B J; Bredeson, C N; Dvorak, C C; Gupta, V; Ho, V T; Lazarus, H M; Marks, D I; Ringdén, O T H; Pasquini, M C; Schriber, J R; Cooke, K R.
Afiliação
  • Olsson RF; 1] Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden [2] Centre for Clinical Research Sörmland, Uppsala University, Uppsala, Sweden.
  • Logan BR; 1] CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA [2] Division of Biostatistics, Institute for Health and Society, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Chaudhury S; Division of Pediatric Hematology, Oncology and Stem Cell Transplant, Department of Pediatrics, Ann & Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA.
  • Zhu X; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Akpek G; Section of Hematology/Oncology, Banner MD Anderson Cancer Center, Gilbert, AZ, USA.
  • Bolwell BJ; Department of Hematology and Oncology, Cleveland Clinic, Cleveland, OH, USA.
  • Bredeson CN; The Ottawa Hospital Blood and Marrow Transplant Program and the Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
  • Dvorak CC; Department of Pediatrics, University of California San Francisco Medical Center, San Francisco, CA, USA.
  • Gupta V; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Ho VT; Center for Hematologic Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Lazarus HM; Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, OH, USA.
  • Marks DI; Pediatric Bone Marrow Transplant, University Hospitals Bristol NHS Trust, Bristol, UK.
  • Ringdén OT; 1] Division of Therapeutic Immunology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden [2] Centre for Allogeneic Stem Cell Transplantation, Stockholm, Sweden.
  • Pasquini MC; CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Schriber JR; 1] Cancer Transplant Institute, Virginia G Piper Cancer Center, Scottsdale, AZ, USA [2] Arizona Oncology, Scottsdale, AZ, USA.
  • Cooke KR; Pediatric Blood and Marrow Transplantation Program, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.
Leukemia ; 29(8): 1754-62, 2015 Aug.
Article em En | MEDLINE | ID: mdl-25772027

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Condicionamento Pré-Transplante / Disfunção Primária do Enxerto / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Neoplasias Hematológicas / Condicionamento Pré-Transplante / Disfunção Primária do Enxerto / Doença Enxerto-Hospedeiro Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article